The impact of neuropsychological functioning on adherence to HAART in HIV-infected substance abuse patients

Allison J. Applebaum, Laura C. Reilly, Jeffrey S. Gonzalez, Mark A. Richardson, Catherine L. Leveroni, Steven Safren

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

This study assessed the frequency of neuropsychological impairment and its relationship to adherence in a sample of HIV-infected injection drug users (IDUs) in treatment. One hundred eight participants recruited between September 2006 and October 2008 completed psychodiagnostic and neuropsychological assessments and monitored HAART adherence over a 2-week period via the use of Medication Event Monitoring System (MEMS) electronic pill caps and self-report. Assessment of concurrent functioning included clinician-rated scales of depression and substance use severity, and a battery of neuropsychological tests. Findings from individual neuropsychological tests were converted to Z scores relative to standard norms and averaged to form a composite score (NPZ). NPZ was generally poor (mean/-1.505, standard deviation/1.120), with 76.9% of the sample being classified as highly impaired. Self-reported adherence was significantly higher than MEMS cap adherence. In contrast with previous studies, overall neuropsych logical functioning was not a significant predictor of electronically monitored or self-reported adherence. However, examiner-rated current global severity of substance use and delayed word list recall emerged as significant predictors of self-reported adherence. Additionally, estimated premorbid verbal intelligence emerged as a significant predictor of the discrepancy between electronically monitored and self-reported adherence. Given the extent of neuropsychological impairment in this sample, future studies should examine the degree to which the impact of neuropsychological impairment may moderate interventions for this population, and the extent to which skills to cope with neuropsychological problems may boost the potential efficacy of such interventions.

Original languageEnglish (US)
Pages (from-to)455-462
Number of pages8
JournalAIDS Patient Care and STDs
Volume23
Issue number6
DOIs
StatePublished - Jun 1 2009
Externally publishedYes

Fingerprint

Neuropsychological Tests
Highly Active Antiretroviral Therapy
Substance-Related Disorders
HIV
Drug Users
Intelligence
Self Report
Depression
Injections
Population
Therapeutics

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

The impact of neuropsychological functioning on adherence to HAART in HIV-infected substance abuse patients. / Applebaum, Allison J.; Reilly, Laura C.; Gonzalez, Jeffrey S.; Richardson, Mark A.; Leveroni, Catherine L.; Safren, Steven.

In: AIDS Patient Care and STDs, Vol. 23, No. 6, 01.06.2009, p. 455-462.

Research output: Contribution to journalArticle

Applebaum, Allison J. ; Reilly, Laura C. ; Gonzalez, Jeffrey S. ; Richardson, Mark A. ; Leveroni, Catherine L. ; Safren, Steven. / The impact of neuropsychological functioning on adherence to HAART in HIV-infected substance abuse patients. In: AIDS Patient Care and STDs. 2009 ; Vol. 23, No. 6. pp. 455-462.
@article{8a11c192f8e94cb1ac4877ad508f9d74,
title = "The impact of neuropsychological functioning on adherence to HAART in HIV-infected substance abuse patients",
abstract = "This study assessed the frequency of neuropsychological impairment and its relationship to adherence in a sample of HIV-infected injection drug users (IDUs) in treatment. One hundred eight participants recruited between September 2006 and October 2008 completed psychodiagnostic and neuropsychological assessments and monitored HAART adherence over a 2-week period via the use of Medication Event Monitoring System (MEMS) electronic pill caps and self-report. Assessment of concurrent functioning included clinician-rated scales of depression and substance use severity, and a battery of neuropsychological tests. Findings from individual neuropsychological tests were converted to Z scores relative to standard norms and averaged to form a composite score (NPZ). NPZ was generally poor (mean/-1.505, standard deviation/1.120), with 76.9{\%} of the sample being classified as highly impaired. Self-reported adherence was significantly higher than MEMS cap adherence. In contrast with previous studies, overall neuropsych logical functioning was not a significant predictor of electronically monitored or self-reported adherence. However, examiner-rated current global severity of substance use and delayed word list recall emerged as significant predictors of self-reported adherence. Additionally, estimated premorbid verbal intelligence emerged as a significant predictor of the discrepancy between electronically monitored and self-reported adherence. Given the extent of neuropsychological impairment in this sample, future studies should examine the degree to which the impact of neuropsychological impairment may moderate interventions for this population, and the extent to which skills to cope with neuropsychological problems may boost the potential efficacy of such interventions.",
author = "Applebaum, {Allison J.} and Reilly, {Laura C.} and Gonzalez, {Jeffrey S.} and Richardson, {Mark A.} and Leveroni, {Catherine L.} and Steven Safren",
year = "2009",
month = "6",
day = "1",
doi = "10.1089/apc.2008.0181",
language = "English (US)",
volume = "23",
pages = "455--462",
journal = "AIDS Patient Care and STDs",
issn = "1087-2914",
publisher = "Mary Ann Liebert Inc.",
number = "6",

}

TY - JOUR

T1 - The impact of neuropsychological functioning on adherence to HAART in HIV-infected substance abuse patients

AU - Applebaum, Allison J.

AU - Reilly, Laura C.

AU - Gonzalez, Jeffrey S.

AU - Richardson, Mark A.

AU - Leveroni, Catherine L.

AU - Safren, Steven

PY - 2009/6/1

Y1 - 2009/6/1

N2 - This study assessed the frequency of neuropsychological impairment and its relationship to adherence in a sample of HIV-infected injection drug users (IDUs) in treatment. One hundred eight participants recruited between September 2006 and October 2008 completed psychodiagnostic and neuropsychological assessments and monitored HAART adherence over a 2-week period via the use of Medication Event Monitoring System (MEMS) electronic pill caps and self-report. Assessment of concurrent functioning included clinician-rated scales of depression and substance use severity, and a battery of neuropsychological tests. Findings from individual neuropsychological tests were converted to Z scores relative to standard norms and averaged to form a composite score (NPZ). NPZ was generally poor (mean/-1.505, standard deviation/1.120), with 76.9% of the sample being classified as highly impaired. Self-reported adherence was significantly higher than MEMS cap adherence. In contrast with previous studies, overall neuropsych logical functioning was not a significant predictor of electronically monitored or self-reported adherence. However, examiner-rated current global severity of substance use and delayed word list recall emerged as significant predictors of self-reported adherence. Additionally, estimated premorbid verbal intelligence emerged as a significant predictor of the discrepancy between electronically monitored and self-reported adherence. Given the extent of neuropsychological impairment in this sample, future studies should examine the degree to which the impact of neuropsychological impairment may moderate interventions for this population, and the extent to which skills to cope with neuropsychological problems may boost the potential efficacy of such interventions.

AB - This study assessed the frequency of neuropsychological impairment and its relationship to adherence in a sample of HIV-infected injection drug users (IDUs) in treatment. One hundred eight participants recruited between September 2006 and October 2008 completed psychodiagnostic and neuropsychological assessments and monitored HAART adherence over a 2-week period via the use of Medication Event Monitoring System (MEMS) electronic pill caps and self-report. Assessment of concurrent functioning included clinician-rated scales of depression and substance use severity, and a battery of neuropsychological tests. Findings from individual neuropsychological tests were converted to Z scores relative to standard norms and averaged to form a composite score (NPZ). NPZ was generally poor (mean/-1.505, standard deviation/1.120), with 76.9% of the sample being classified as highly impaired. Self-reported adherence was significantly higher than MEMS cap adherence. In contrast with previous studies, overall neuropsych logical functioning was not a significant predictor of electronically monitored or self-reported adherence. However, examiner-rated current global severity of substance use and delayed word list recall emerged as significant predictors of self-reported adherence. Additionally, estimated premorbid verbal intelligence emerged as a significant predictor of the discrepancy between electronically monitored and self-reported adherence. Given the extent of neuropsychological impairment in this sample, future studies should examine the degree to which the impact of neuropsychological impairment may moderate interventions for this population, and the extent to which skills to cope with neuropsychological problems may boost the potential efficacy of such interventions.

UR - http://www.scopus.com/inward/record.url?scp=67651174414&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67651174414&partnerID=8YFLogxK

U2 - 10.1089/apc.2008.0181

DO - 10.1089/apc.2008.0181

M3 - Article

C2 - 19519229

AN - SCOPUS:67651174414

VL - 23

SP - 455

EP - 462

JO - AIDS Patient Care and STDs

JF - AIDS Patient Care and STDs

SN - 1087-2914

IS - 6

ER -